Skip to content

A prospective, multicenter, self-controlled trial to evaluate the efficacy and safety of an implanted spinal cord nerve stimulator system for patients with limb spasticity and pain following brain injury

A prospective, multicenter, self-controlled trial to evaluate the efficacy and safety of an implanted spinal cord nerve stimulator system for patients with limb spasticity and pain following brain injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119629
Enrollment
Unknown
Registered
2026-03-02
Start date
2026-03-03
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Surgical group:Test treatment: Electrode implantation surgery

Sponsors

Jinan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The presence of limb spasticity accompanied by pain for a period of at least 6 months after brain injury; 2) Age between 18 and 70 years old; 3) The selected patients have a Fugl-Meyer score of at least 50 points (with MAS assessment of at least grade 3 or NRS of at least 3 points or NPQ of at least 10 points); 4) There is a significant improvement in limb spasticity or pain during the test period, and the subjects and their families have a strong willingness to undergo permanent implantation of the stimulator; 5) The subjects have a certain ability to understand and express themselves, and voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Persistent breathing difficulties exist; 2) Language or cognitive impairments are present; 3) Severe depression (Beck Depression Inventory score >=16); 4) Progressive brain disease is currently present; 5) There are surgical contraindications (e.g., history of adverse reactions to anesthetics, the surgeon deems the patient unsuitable for surgery, etc.); 6) Other stimulating devices such as pacemakers or other nerve stimulators are being used in the body, or other experimental devices or drugs are in use; 7) There is a requirement for heat therapy during the current period or the trial; 8) Obvious joint deformities exist; 9) Obvious tactile reduction exists; 10) Pregnant and lactating women, and patients who cannot take appropriate contraceptive measures during the trial.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer motor function score, FMA-UE;Modified Ashworth Spasticity Scale, MAS;Numerical Rating Scale, NRS;Neuropathic Pain Scale, NPQ;Neuroelectrophysiology, EMG/SSEP;

Countries

China

Contacts

Public ContactSu Daoqing

Jinan Central Hospital (Capital Medical University Xuanwu Hospital Jinan Hospital)

daoqingsu@163.com+86 195 8897 0697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026